Indian Big Pharma, Big Dividends

Abbott India

Market Cap: ₹617.7b

Operates as a pharmaceutical company in India.

Cipla

Market Cap: ₹1.2t

Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹1.1t

Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.

Alkem Laboratories

Market Cap: ₹658.4b

A pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.1t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹285.2b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Lupin

Market Cap: ₹964.8b

Operates as a pharmaceutical company in India, the United States, and internationally.

Zydus Lifesciences

Market Cap: ₹920.1b

Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.3t

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

Pfizer

Market Cap: ₹228.2b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹418.6b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Aurobindo Pharma

Market Cap: ₹687.1b

A biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.

Eris Lifesciences

Market Cap: ₹205.1b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Ajanta Pharma

Market Cap: ₹345.8b

A pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages.

Ipca Laboratories

Market Cap: ₹360.0b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia.

Gland Pharma

Market Cap: ₹283.7b

Engages in manufacturing and sale of injectable formulations in India, the United States, Europe, Canada, Australia, New Zealand, and internationally.